Fortive Corporation enters its June 9 earnings call with short sellers steadily unwinding positions — but the analyst community remains cautious, and options traders are nowhere near as defensive as they were just weeks ago.
Short interest has fallen sharply. From a peak near 4.9% of the free float in early May, the estimated short position has dropped to 3.7% — a decline of roughly 16% over the past month, with an 11.6% reduction this week alone. That unwinding isn't being driven by a short squeeze; the borrow market is relaxed, with availability running above 600% of the currently shorted interest, meaning shares to borrow are plentiful. Cost to borrow remains negligible at 0.47%, barely off its recent floor despite ticking up 3% on the week. The picture here is shorts choosing to cover, not being forced out.
Options sentiment has shifted dramatically since late April. Through most of April, the put/call ratio was running above 3.0 — a heavily defensive setup by any measure, peaking at 4.1 on April 30. That level has collapsed to 0.94 today, well below the 20-day mean of 1.45. The z-score is mildly negative at -0.58, suggesting options traders have moved from near-maximum caution to a relatively neutral posture. The shift coincides almost exactly with the short-covering trend — both sets of market participants appear to have stepped back from their most bearish positioning ahead of the print.
The Street reflects a similar ambivalence. Morgan Stanley maintained its Equal-Weight rating this week, nudging its target to $59 — still below the current price of $60.16. JP Morgan held at Underweight with a $64 target. Argus Research upgraded to Buy in May with a $68 target, a move that stands out as the lone bullish outlier among recent actions. The cluster of neutral and sidelined ratings has pushed the mean consensus target to $63.63, implying around 6% upside — a modest return expectation that reflects the Street's broadly hold-level conviction. The EV/EBITDA multiple of 15.9x has risen about 2% over 30 days, suggesting the market has quietly re-rated the stock higher even as analysts have stayed guarded. The dividend score ranks in the 91st percentile, though the most recent dividend data is stale and the yield is not a current driver.
The bear case centres on Healthcare Solutions segment headwinds — particularly exposure to government contracting and hospital capex caution — alongside a rising tax rate. Bulls point to free cash flow generation, recurring revenue mix, and the bolt-on M&A pipeline. T. Rowe Price added 2.7 million shares and Viking Global built a 3.25 million-share position in Q1 filings, suggesting some larger money has been constructive on the name. The Chief Legal Officer sold $2.9 million in May, the most material insider transaction in recent months, but at a significance score of 2 it reads more like routine liquidation than a signal.
The last two earnings prints are the clearest thing to watch now. Fortive fell 4.4% the day after its April 30 release, and 3.2% after the prior quarter's print — both fades, each partly recovering over the following five days. With shorts freshly covered, options relatively neutral, and the Street clustered around holds, the setup heading into June 9 is one where the data tells less of a directional story and more about whether Fortive can give the Healthcare segment bears a reason to stop pressing.
See the live data behind this article on ORTEX.
Open FTV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
